Learn More
Medchemexpress LLC Propanamide, 2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]- | 52806-53-8 | 99.8% | 292.21 | 100 MG

Supplier: Medchemexpress LLC HYW013272100MG
Hydroxyflutamide (HFT) is an orally active metabolite of Flutamide, functioning as a potent androgen receptor antagonist with an IC50 of 700 nM. This compound has demonstrated effects on embryonic and reproductive tract development in mice and can enhance the efficacy of Bacillus Calmette-Guérin (BCG) in inhibiting bladder cancer progression. It is utilized in research concerning tumors and reproductive diseases, impacting targets such as Akt, PI3K, Gap Junction Protein, and Integrin.
- Potent androgen receptor antagonist with an IC50 of 700 nM
- Orally active metabolite
- Influences embryonic and reproductive tract development
- Enhances Bacillus Calmette-Guérin (BCG) efficacy against bladder cancer
- Useful in tumor and reproductive disease research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.